Tylenol-Maker Kenvue Keeps Growth Outlook, Lowers Margin Target

Tylenol-Maker Kenvue Keeps Growth Outlook, Lowers Margin Target

Kenvue Inc. maintained its sales expectations for the year while lowering its profitability target as tariffs raise costs.

Kenvue Reports First Quarter 2025 Results - The Morning Sun

SUMMIT, N.J.--(BUSINESS WIRE)--May 8, 2025--Kenvue Inc. (NYSE: KVUE) today announced financial results for the first quarter ended March 30, 2025.“In Q1, our teams executed our plans while continuing to navigate an evolving macro and consumer environment,” said Thibaut Mongon, Chief Executive Officer. “We are committed and focused on activating our brands while staying agile and flexible to accelerate sustainable profitable growth.”First Quarter…